GPhA responds to Senate HELP committee's GDUFA hearing

The Generic Pharmaceutical Association (GPhA) has applauded progress at the federal level on issues affecting it, including a hearing of the Senate Committee on Health, Education, Labor and Pensions (HELP). The session—centered around the Generic Drug User Fee Amendments—drew accolades from the group for underscoring the need to remove barriers to generic competition. David Gaugh, senior vice president of sciences and regulatory affairs, said GPhA also welcomed a vow by Dr.